Secondary Squamous Cell Carcinoma of the Tongue Complicated with Bronchiolitis Obliterans as a Manifestation of Graft-versus-Host Disease following Peripheral Blood Stem Cell Transplantation

Peripheral blood stem cell transplantation (PBSCT) has increasingly been used for hematologic cancer therapy, resulting in improved survival rates. However, risks include graft-versus-host disease (GVHD) and secondary solid tumors. Here, we describe a case of tongue squamous cell carcinoma (SCC) complicated by bronchiolitis obliterans (BO) following PBSCT. A 42-year-old man with a history of acute lymphocytic leukemia treated with PBSCT presented with multiple white lesions and erosions on the tongue and buccal mucosa that are compatible with oral chronic GVHD (NIH criteria: score 2). The lesions were presented for 8 years. The patient had a history of BO manifested as GVHD. During follow-up, an exophytic mass was rapidly developed on the left dorsum of the tongue. Biopsy of this lesion confirmed SCC (cT2N0M0). Pulmonary function testing for general anesthesia was almost normal. Hemiglossectomy, supraomohyoid neck dissection, and tongue reconstruction were performed. Thirteen months after surgery, the patient showed neither recurrence of tumor nor progression of oral GVHD. However, the patient died of respiratory failure due to repeated pneumothoraxes and deterioration of BO.

[1]  K. Kawa,et al.  Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  S. Steinberg,et al.  Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures , 2014, Bone Marrow Transplantation.

[3]  W. Marsden I and J , 2012 .

[4]  C. Marchetti,et al.  Multiple squamous cell carcinomas of the oral cavity in a young patient with graft-versus-host disease following allogenic bone marrow transplantation. , 2011, International journal of oral and maxillofacial surgery.

[5]  K. Stevenson,et al.  Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes , 2011, Bone Marrow Transplantation.

[6]  Akihiro Miyazaki,et al.  Oral cancer in patients after hematopoietic stem-cell transplantation: long-term follow-up suggests an increased risk for recurrence. , 2010, Transplantation.

[7]  K. Wood,et al.  Bronchiolitis obliterans and the risk of pneumothorax after transbronchial biopsy , 2010 .

[8]  A. Kruse,et al.  Oral carcinoma after hematopoietic stem cell transplantation – a new classification based on a literature review over 30 years , 2009, Head & neck oncology.

[9]  I. Alevizos,et al.  Oral graft-versus-host disease. , 2008, Oral diseases.

[10]  J. Klein,et al.  Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. , 2005, Chest.

[11]  W. Travis,et al.  Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. , 2005, Blood.

[12]  P. Hassoun,et al.  Pulmonary complications of bone marrow transplantation. , 1996, Chest.